COVID-19
+1
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
Sponsored by University of California, San Diego
About this trial
Last updated 2 years ago
Study ID
806121
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
All
All
Trial Timing
Ended 9 months ago
What is this trial about?
Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been
persistently high in San Diego County's central and southern communities near the United
States/Mexico border. These regions predominantly house Latino residents, the ethnic minority
community most impacted by COVID-19 in San Diego. In the Phase I project, University of
California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action
Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San
Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the
project tested >10,000 community members (92% Latino) and received requests to scale-out the
testing program to additional primary care clinic sites.
In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And
TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical
partners to refine, specify, implement, and evaluate an implementation strategy bundle that
optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing
to FDA-authorized COVID-19 rapid antigen testing.
What are the participation requirements?
Inclusion Criteria
- Speak English and/or Spanish
- Affiliated with San Ysidro Health as a patient at select clinics (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights) OR
- A member of a community near a San Ysidro Health clinic (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights).
Exclusion Criteria
- Institutionalization for psychiatric disorder, developmental delay, or criminal activity.
- Unable to provide informed consent.